By Conjoint Professor Dedee Frances Murrell

Book Chapters

Lehman JS; Murrell DF; Camilleri MJ; Kalaaji AN, 2015, 'Prevention and Treatment of Infections in Patients with Autoimmune Blistering Disease', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 611 - 615, http://dx.doi.org/10.1007/978-3-662-45698-9_65

Cianchini G; Paradisi A; Murrell DF, 2015, 'Quality of Life in Autoimmune Blistering Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 623 - 631, http://dx.doi.org/10.1007/978-3-662-45698-9_67

Kho YC; Daniel BS; Murrell DF; Joly P, 2015, 'Rituximab and Its Use in Autoimmune Bullous Disorders', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 523 - 529, http://dx.doi.org/10.1007/978-3-662-45698-9_53

Tan JCK; Coroneo M; Martinez A; Tosti A; Murrell DF, 2015, 'Special Issues in Epidermolysis Bullosa: Eyes, Hair, Nails, Teeth and Pregnancy', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 695 - 709, http://dx.doi.org/10.1007/978-3-662-45698-9_73

Bruckner AL; Pope E; Mellerio JE; Bodemer C; Colomb V; Diem A; Murrell DF, 2015, 'Supportive Care: Bathing, Wound Care, Nutrition, Pain and Itch Management, Psychosocial Support, Palliation', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 653 - 666, http://dx.doi.org/10.1007/978-3-662-45698-9_70

Lazo-Dizon JPH; Murrell DF, 2015, 'Tetracyclines and Their Use in Autoimmune Bullous Diseases and Epidermolysis Bullosa', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 501 - 505, http://dx.doi.org/10.1007/978-3-662-45698-9_50

Brennan FP; Lim CHL; Murrell DF, 2015, 'The Pathogenesis, Assessment and Management of Pruritus in Autoimmune Bullous Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 643 - 649, http://dx.doi.org/10.1007/978-3-662-45698-9_69

Kim J; Daniel BS; Werth VP; Joly P; Murrell DF, 2015, 'The Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 533 - 541, http://dx.doi.org/10.1007/978-3-662-45698-9_54

Micheletti RG; Murrell DF; Werth VP, 2015, 'Treatment and Prevention of Glucocorticoid-Induced Osteoporosis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 593 - 603, http://dx.doi.org/10.1007/978-3-662-45698-9_63

George R; Cardones ARG; Murrell DF; Hall RP, 2015, 'Treatment of Dermatitis Herpetiformis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 573 - 578, http://dx.doi.org/10.1007/978-3-662-45698-9_60

Kim M; Lucky AW; Azizkhan RG; Bernardis C; Murrell DF, 2015, 'Treatment of EB Complications: Esophageal Strictures, Pseudosyndactyly, Urethral and Meatal Stenosis, and Laryngeal Stenosis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 687 - 694, http://dx.doi.org/10.1007/978-3-662-45698-9_72

Chee SN; Murrell DF, 2015, 'Using Intravenous Immunoglobulins in Autoimmune Bullous Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 515 - 521, http://dx.doi.org/10.1007/978-3-662-45698-9_52

Martin LK; Sperber BR; Murrell DF; Werth VP, 2014, 'Pemphigus', in Evidence Based Dermatology Third Edition, pp. 552 - 560, http://dx.doi.org/10.1002/9781118357606.ch65

Intong LRA; Murrell DF, 2011, 'Erythema Multiforme, Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis', in Harper S Textbook of Pediatric Dermatology Volume 1 Thrid Edition, pp. 78.1 - 78.8, http://dx.doi.org/10.1002/9781444345384.ch78

Venugopal SS; Murrell DF, 2011, 'Diagnosis and Prevention of Bullous Diseases', in Preventive Dermatology in Infectious Diseases, Springer London, pp. 53 - 73, http://dx.doi.org/10.1007/978-0-85729-847-8_6

Leonard T; Delamere F; Murrell D, 2009, 'The Cochrane Skin Group', in Evidence Based Dermatology Second Edition, pp. 20 - 25, http://dx.doi.org/10.1002/9781444300161.ch4

Khumalo NP; Kirtschig G; Middleton PM; Hollis S; Wojnarowska F; Murrell DF, 2003, 'Interventions for bullous pemphigoid', in The Cochrane Library, John Wiley & Sons, UK

Kirtschig G; Murrell DF; Wojnarowska F; Khumalo NP, 2003, 'Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita (Cochrane Review)', in Cochrane Database of Systematic Reviews, John Wiley & Sons Ltd, England

Leonard T; Delamere F; Murrell DF, 2003, 'The Cochrane Skin Group', in Williams H; Bigby M; Diepgen T; Herxheimer A; Naldi L; Rzany B (ed.), Evidence-based Dermatology, BMJ Publishing Group, London, UK, pp. 24 - 32

Journal articles

Akbarialiabad H; Schmidt E; Patsatsi A; Lim YL; Mosam A; Tasanen K; Yamagami J; Daneshpazhooh M; De D; Cardones ARG; Joly P; Murrell DF, 2025, 'Author Correction: Bullous pemphigoid (Nature Reviews Disease Primers, (2025), 11, 1, (12), 10.1038/s41572-025-00595-5)', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00605-6

Akbarialiabad H; Schmidt E; Patsatsi A; Lim YL; Mosam A; Tasanen K; Yamagami J; Daneshpazhooh M; De D; Cardones ARG; Joly P; Murrell DF, 2025, 'Bullous pemphigoid', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00595-5

Akbarialiabad H; Salehi S; Murrell DF; Jafferany M, 2025, 'Morgellons disease: a review on current evidence and the need for consensus, standardized criteria, and future randomized controlled trials', Archives of Dermatological Research, 317, http://dx.doi.org/10.1007/s00403-025-04308-6

Sarsam S; He A; Murrell DF, 2025, 'Ofatumumab for the management of refractory pemphigus vulgaris: A case series', Jaad International, 22, pp. 94 - 96, http://dx.doi.org/10.1016/j.jdin.2025.05.018

Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Murrell DF; Pustisek N; Svensson A; Marron SE; Sampogna F; Bewley A; Salavastru C; Koumaki D; Suru A; Yordanova IA; Zemskov S; Tsymbaliuk R; Ostapko O; Augustin M; Abeni D; Szepietowski JC; Jemec GB, 2025, 'Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts', International Journal of Dermatology, 64, pp. 1546 - 1557, http://dx.doi.org/10.1111/ijd.17668

Niknam N; Akbarialiabad H; Farjoud Kouhanjani M; Kolaparambil Varghese LJ; Berrington de González A; Melin MM; Shafie’ei M; Mousavi SM; Hosseini SA; Taha SR; Russomano T; Murrell DF; Grada A; Leachman SA; Akbari Z; Derisi AJ; Jurga M; Kumar A; Das S; D’Urbano J; Hakim G; Sadeghian N; Paydar S; Tarbox M; West C; Ghorashi SM; Hosseini SH; Squire T; Bunick CG; Christiansen R, 2025, 'Space Oncology: A Comprehensive Scoping Review', Wilderness and Environmental Medicine, 36, pp. 148 - 171, http://dx.doi.org/10.1177/10806032251349442

Cascio Ingurgio R; Alfano A; Matteodo E; Stark M; Valenti M; Narcisi A; Costanzo A; Murrell DF, 2025, 'Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation.', Australas J Dermatol, http://dx.doi.org/10.1111/ajd.14592

Cascio Ingurgio R; Alfano A; Gargiulo L; Ibba L; Narcisi A; Satgé F; Stark M; Costanzo A; Murrell DF, 2025, 'Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two Centres', Australasian Journal of Dermatology, 66, pp. 305 - 308, http://dx.doi.org/10.1111/ajd.14532

Gooderham M; Torres T; Imafuku S; Rademaker M; Prajapati VH; Tsianakas A; Murrell DF; Owczarek W; Han Y; Lee W-J; Levy G; Ibrahim N; Moreira A; Shams K, 2025, 'Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up).', Br J Dermatol, http://dx.doi.org/10.1093/bjd/ljaf236

Sarsam S; Koszegi BJ; Murrell DF, 2025, 'Colchicine as a treatment option for inherited epidermolysis bullosa', Clinical and Experimental Dermatology, 50, pp. 1238 - 1240, http://dx.doi.org/10.1093/ced/llaf016

Akbarialiabad H; Jamshidi P; Callen JP; Murrell DF, 2025, 'Dermatologic manifestations of hereditary hemochromatosis: A systematic review', Journal of the European Academy of Dermatology and Venereology, 39, pp. 976 - 986, http://dx.doi.org/10.1111/jdv.20098

Tanemura C; Nunotani M; Kawabata K; Morooka Y; Yamagami J; Kakuta R; Saito Y; Kurihara Y; Takahashi H; Ishii N; Koga H; Nakama T; Hayashi D; Hiroyasu S; Tateishi C; Tsuruta D; Murrell DF; Hashimoto T, 2025, 'Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires', Journal of Dermatology, 52, pp. 812 - 830, http://dx.doi.org/10.1111/1346-8138.17707

Akbarialiabad H; Jamshidi P; Aminzade Z; Azizi N; Taha SR; Sadeghian N; Varghese LJK; Kouhanjani MF; Niknam N; Babocs D; El-Assaad F; Russomano T; Murrell DF; Paydar S; Bunick CG; Christiansen R; Mark Melin M, 2025, 'Leveraging space innovations for cancer breakthroughs on Earth', Trends in Cancer, 11, pp. 433 - 440, http://dx.doi.org/10.1016/j.trecan.2025.02.003

Wang MA; Wilson A; Boucher D; Johal JS; Rosenthal NK; Cowan T; Koszegi B; Lara Rivero AD; Daniel BS; Martin LK; Kern JS; Murrell DF, 2025, 'The development and validation of an investigator global assessment score for keratosis pilaris', Journal of the European Academy of Dermatology and Venereology, 39, pp. e350 - e352, http://dx.doi.org/10.1111/jdv.20326

Karakioulaki M; Dunn P; Murrell DF; Payne A; Schmidt E; Werth V; Yale M; Yamagami J; Aoki V; Borradori L; Caux F; Culton D; Daneshpazhooh M; De D; Fairley J; Hammers C; Hertl M; Holtsche M; Joly P; Koga H; Maverakis E; Mosam A; Pan M; Pincelli C; Saleh MA; Sinha AA; Solimani F; Sprecher E; Tasanen K; Tull TJ; Van Beek N; Vielmuth F; Yayli S; Patsatsi A, 2025, 'Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece', Jid Innovations, 5, http://dx.doi.org/10.1016/j.xjidi.2024.100339

Walter S; Murrell DF; Pratama R; Kizny Gordon AE; McIver CJ, 2025, 'Assessment of a Real-Time PCR Assay for the Detection of Dermatophytosis by Sampling With an Adhesive Tape Technique', Australasian Journal of Dermatology, 66, pp. e60 - e61, http://dx.doi.org/10.1111/ajd.14415

Zhou AE; Jain NP; Gronbeck C; Sloan B; Murrell DF; Grant-Kels JM, 2025, 'Ethics of publication mills and payment for guaranteed authorships', Journal of the American Academy of Dermatology, 92, pp. 666 - 667, http://dx.doi.org/10.1016/j.jaad.2024.10.034

Walter S; Murrell DF, 2025, 'Toward gender equity for all members of the academic dermatology community', Clinics in Dermatology, 43, pp. 248 - 250, http://dx.doi.org/10.1016/j.clindermatol.2025.01.004

He A; Koszegi B; Uzun S; Bilgic A; Bozca BC; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Kakuta R; Takahashi H; Nery D; Mundin C; Ramirez-Quizon M; Culton D; McAlpine S; Johal J; Shulruf B; Stone JH; Murrell DF, 2025, 'Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathy', Journal of the European Academy of Dermatology and Venereology, 39, pp. 340 - 349, http://dx.doi.org/10.1111/jdv.20149

Murrell DF, 2025, 'Body image disturbance has severe psychosocial impacts in patients suffering from autoimmune blistering diseases', Journal of the European Academy of Dermatology and Venereology, 39, pp. 253 - 254, http://dx.doi.org/10.1111/jdv.20491

Werth VP; Murrell DF; Joly P; Ardeleanu M; Hultsch V, 2025, 'Bullous pemphigoid burden of disease, management and unmet therapeutic needs', Journal of the European Academy of Dermatology and Venereology, 39, pp. 290 - 300, http://dx.doi.org/10.1111/jdv.20313

Aung T; Noakes R; Kasem K; Murrell DF, 2025, 'Linear Focal Elastosis: What We Know From Epidemiological Studies', Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.14569

Lee H; Cowan TL; Huang C; Wilson A; Koszegi B; Stone C; Ng J; Sarsam S; Akbarialiabad H; Johal JS; Murrell OGC; Wittal RA; Murrell DF; Daniel BS, 2025, 'Pilot Study of Tildrakizumab in the Treatment of Stable Non-Segmental Vitiligo', JEADV Clinical Practice, http://dx.doi.org/10.1002/jvc2.70113

Chernyshov PV; Finlay AY; Patsatsi A; Marinović B; Salavastru C; Murrell DF; Tomas-Aragones L; Poot F; Pustisek N; Svensson A; Marron SE; Sampogna F; Bewley A; Koumaki D; Suru A; Abeni D; Salek SS; Gregoriou S; Antiga E; Werth VP; Augustin M; Szepietowski JC; Schmidt E, 2025, 'Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases', International Journal of Dermatology, http://dx.doi.org/10.1111/ijd.17964

Haag C; Alexis A; Aoki V; Bissonnette R; Blauvelt A; Chovatiya R; Cork MJ; Danby SG; Eichenfield LF; Eyerich K; Gooderham M; Guttman-Yassky E; Hijnen DJ; Irvine AD; Katoh N; Murrell DF; Leshem YA; Levin AA; Vittrup I; Olydam JI; Orfali RL; Paller AS; Renert-Yuval Y; Rosmarin D; Silverberg JI; Thyssen JP; Ständer S; Stefanovic N; Todd G; Yu JD; Simpson EL, 2024, 'A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council', British Journal of Dermatology, 192, pp. 135 - 143, http://dx.doi.org/10.1093/bjd/ljae342

Hachem ME; Diociaiuti A; Zambruno G; Samela T; Ferretti F; Carnevale C; Linertová R; Bodemer C; Murrell DF; Abeni D, 2024, '“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires', Italian Journal of Pediatrics, 50, http://dx.doi.org/10.1186/s13052-024-01657-2

Akbarialiabad H; Pasdar A; Murrell DF, 2024, 'Digital twins in dermatology, current status, and the road ahead', Npj Digital Medicine, 7, http://dx.doi.org/10.1038/s41746-024-01220-7

Werth VP; Murrell DF; Joly P; Heck R; Orengo JM; Ardeleanu M; Hultsch V, 2024, 'Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)', Advances in Therapy, 41, pp. 4418 - 4432, http://dx.doi.org/10.1007/s12325-024-02992-w

Akbarialiabad H; Grant-Kels JM; Murrell DF, 2024, 'A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists', Clinics in Dermatology, 42, pp. 723 - 726, http://dx.doi.org/10.1016/j.clindermatol.2024.05.008

Tseng H; Stone C; Shulruf B; Murrell DF, 2024, 'Establishing minimal clinically important differences for the Pemphigus Disease Area Index', British Journal of Dermatology, 191, pp. 823 - 831, http://dx.doi.org/10.1093/bjd/ljae283

Kiritsi D; Schauer F; Gewert S; Reineker K; Reimer-Taschenbrecker A; Schwieger-Briel A; Ott H; Schmoor C; Grishina O; Murrell D; Stiller B; Zahn T; Nyström A; Bruckner-Tuderman L, 2024, 'Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial', Eclinicalmedicine, 77, http://dx.doi.org/10.1016/j.eclinm.2024.102900

Back to profile page